RT Book, Section A1 Willis, Martha W. A1 Wiseman, Amy L. A1 McGill, Ashley A1 Leonard, Karen A1 Wilson, Heather A1 Thomas, Cameron A2 Hershey, Andrew D. SR Print(0) ID 1195237343 T1 Pediatric Syncope and Related Phenomena T2 CURRENT Diagnosis & Treatment Pediatric Neurology YR 2023 FD 2023 PB McGraw Hill Education PP New York, NY SN 9781260457520 LK neurology.mhmedical.com/content.aspx?aid=1195237343 RD 2024/04/19 AB Syncope is a relatively sudden, brief, self-limited loss of postural tone and consciousness followed by rapid spontaneous recovery without any neurologic sequelae.1-3 Syncope is a common pediatric problem, representing 1% to 3% of all pediatric emergency department (ED) visits and 6% of hospital admissions. It has an estimated population incidence of 10% to 15%.4,5 In children and adolescents, syncope is substantially more common in females (65.6% female, 34.4% male). Although syncope can occur in any demographic group throughout the world, in North America, those who seek medical care for this complaint are more likely to be White and have private insurance.1,5,6 For instance, one study found that 54% of pediatric syncope patients presenting to an East Coast ED were White, whereas 22% were Latino, 16% were Black, and 2% were Asian.7 Of these pediatric ED patients, 68% had private primary insurance and 32% had public insurance.7 Syncope, although not a serious illness and typically benign in etiology, can have high healthcare costs. In a study of one cohort, pediatric syncope accounted for $1.1 million dollars of testing over a 2-year period, with an average cost of $2488 per patient.1 Much of this testing was unnecessary due to the benign nature of syncope. In addition to being common and having high healthcare costs, syncope deserves attention because it significantly impacts quality of life. Pediatric syncope patients are known to have Pediatric Quality of Life Inventory total scores as low as children and adolescents with other chronic illnesses such as diabetes, asthma, obesity, and end-stage renal disease.6,8-10